临床外科杂志 ›› 2020, Vol. 28 ›› Issue (9): 860-863.doi: 10.3969/j.issn.1005-6483.2020.09.020

• • 上一篇    下一篇

人G补缀FHA域血管生成因子1在三阴性乳腺癌的表达与预后的关系

  

  1. 442000 湖北省十堰市国药东风总医院器官移植乳腺外科
  • 出版日期:2020-09-20 发布日期:2020-09-20
  • 通讯作者: 董小林,Email:newestway@163.com

Clinical significance of AGGF1 expression in triple negative breast cancer

  1. Department of Organ Transplantation and Breast Surgery,Affiliated Dongfeng Hospital,Hubei Universiy of Medicine,Hubei,Shiyan 442000,China
  • Online:2020-09-20 Published:2020-09-20

摘要: 目的 探讨人G补缀FHA域血管生成因子1(AGGF1)蛋白在三阴性乳腺癌中的表达及其意义。
方法 三阴性乳腺癌病人102例,利用免疫组织化学及Western blot法检测AGGF1的表达,分析AGGF1的表达与临床病理特征及生存的关系。
结果 AGGF1的免疫组织化学与Western blot检测结果一致(r=0.859,P=0.00);AGGF1蛋白不同表达与病人年龄、肿瘤大小、TNM分期、淋巴结转移间差异无统计学意义(P>0.05),与Ki-67指标间差异有统计学意义(P<0.05)。三阴性乳腺癌102例,AGGF1蛋白阳性42例,死亡17例; AGGF1蛋白阴性60例,死亡例3例。与AGGF1阴性表达组比较,AGGF1阳性表达组的总生存明显低于阴性表达组,差异有统计学意义(P<0.05)。
结论 AGGF1蛋白阳性表达与三阴性乳腺癌的不良预后相关。有必要进行深入的研究,以明确AGGF1可否成为三阴性乳腺癌潜在的治疗靶点。

关键词: 人G补缀FHA域血管生成因子1, 三阴性, 乳腺癌, 预后

Abstract: Objective To investigate the prognostic significance of AGGF1,which plays an important role in tumor angiogenesis,and its expression in triple negative breast cancer.
Methods Immunohistochemistry and Western blot methods for AGGF1 expression in 102 triple negative breast cancer specimens were detected,study the correlation between AGGF1 expression and various pathologic factors and breast cancer survival.
Results There was positive correlation between the results of Immunohistochemistry and Western blot assay (r=0.859,P=0.00).The expression of AGGF1 in triple negative breast cancer tissues was associated with Ki-67 expression(P<0.05),but not with age,tumor size,TNM stage and lymph node metastasis(P>0.05).The positive and negative expression of AGGF1 were observed in 42 and 60 of all 102 triple negative breast cancer patients.17 and 3 patients died in each group during the follow-up.The positive expression of AGGF1 was correlated with poorer overall survival than the negative expression group(P<0.05).
Conclusion Positive expression of AGGF1 was poor prognostic factor in triple negative breast cancers.Further investigation is essential to determine whether AGGF1 might be effective therapeutic targets for triple negative breast cancer.

Key words: angiogenic factor with G and FHA domains 1; , triple negative, breast cancer, prognosis

[1] 高丹 郑媛 姜冉 陈波 田少林 王蓉 卢文亮. 乳房活检方式对前哨淋巴结活检的影响[J]. 临床外科杂志, 2020, 28(9): 848-851.
[2] 陈革 陈汉雄 侯本新. NOBp1表达水平与乳腺癌临床病理因素及预后相关性[J]. 临床外科杂志, 2020, 28(9): 857-859.
[3] 彭丰 王敏 谢昱 秦仁义. 长链非编码RNA SNHG1在胆管癌中的表达与临床特征及预后的相关性分析[J]. 临床外科杂志, 2020, 28(8): 725-727.
[4] 王韬 张峥嵘 王少圣 武健. 胆囊肉瘤样癌五例临床分析[J]. 临床外科杂志, 2020, 28(8): 744-746.
[5] 任宇 王刚乐. 麦默通旋切术用于乳腺癌病灶切除的临床价值[J]. 临床外科杂志, 2020, 28(8): 764-766.
[6] 郑丽华 吴尚 张晶 张泽鹏 王昕仪 杨天硕 赵亚恒 贺新奇 刘运江. 纤维蛋白原与三阴性乳腺癌总生存期的关系[J]. 临床外科杂志, 2020, 28(8): 767-770.
[7] 徐冉 杨年钊 赵海远 李阳 赵军 张义胜. 多灶性胃癌病人淋巴结转移危险因素及预后分析[J]. 临床外科杂志, 2020, 28(8): 774-777.
[8] 袁俊 李印 彭银杰 凃成志 陈威鹏 秦建军. 术前中性粒细胞与淋巴细胞比值对淋巴结转移的胸段食管鳞癌病人预后的预测价值[J]. 临床外科杂志, 2020, 28(7): 627-630.
[9] 李政委, 王杭州, 朱炳鑫等. 学龄前儿童中重型颅脑损伤预后不良相关因素分析[J]. 临床外科杂志, 2020, 28(6): 545-547.
[10] 于永政, 梁雪妍, 邢娴娴等. 乳腺癌荧光染料法腋窝反向淋巴作图的可行性及安全性研究[J]. 临床外科杂志, 2020, 28(6): 551-553.
[11] 韩加刚, 王振军. 梗阻性左半结肠癌治疗新策略-支架扩张联合新辅助化疗[J]. 临床外科杂志, 2020, 28(5): 401-403.
[12] 狄子杨, 唐强, 狄茂军等. 腹腔热灌注化疗治疗晚期结直肠癌的疗效分析[J]. 临床外科杂志, 2020, 28(5): 433-436.
[13] 蔡华霞, 王曙逢. 联合中性粒细胞/淋巴细胞比值与纤维蛋白原在分析胃肠道间质瘤预后中的价值[J]. 临床外科杂志, 2020, 28(5): 452-455.
[14] 查正彪, 潘友民, 郑智等. Stanford A型主动脉夹层术后急性肾功能损伤危险因素分析及预后[J]. 临床外科杂志, 2020, 28(5): 467-470.
[15] 王序杰, 周岩冰. 机器人直肠癌手术现状[J]. 临床外科杂志, 2020, 28(5): 489-492.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!